Nga TQ Nguyen
Biographic Data
| ID | 6072909 |
|---|---|
| NAME | Nga TQ Nguyen |
| GIVEN NAMES | Nga TQ |
| FAMILY NAME | Nguyen |
| SIGNATURE | NGUYEN N T |
| AFFILIATIONS | Nga TQ. Nguyen is with the Department of Pharmaceutical Administration, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam. Hoa Q. Nguyen is with the Department of Clinical Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam and the School of Pharmacy, Queen’s University, Belfast, UK. Ciaran O’Neill is with the Centre for Public Health, Queen’s University, Belfast, UK. |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Covid-19 Era Recessional Mortality Continues the Impact of Prepandemic Recessions on Mortality
Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the Advance Trial in Vietnam
Introduction: ADVANCE was a large, multinational clinical study conducted over 5 years in type 2 diabetes mellitus (T2DM). In all, 11,140 patients were randomly assigned to receive gliclazide-based intensive glucose control (IGC) or standard glucose control (SGC). IGC was shown to significantly reduce the incidence of major macrovascular and microvascular events (composite endpoint) or major microvascular events compared with SGC, primarily by en…
No prominent works on this page.
Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the Advance Trial in Vietnam
Introduction: ADVANCE was a large, multinational clinical study conducted over 5 years in type 2 diabetes mellitus (T2DM). In all, 11,140 patients were randomly assigned to receive gliclazide-based intensive glucose control (IGC) or standard glucose control (SGC). IGC was shown to significantly reduce the incidence of major macrovascular and microvascular events (composite endpoint) or major microvascular events compared with SGC, primarily by en…
Covid-19 Era Recessional Mortality Continues the Impact of Prepandemic Recessions on Mortality
Internal Medicine (2 works) · Medicine (2 works) · 2019-20 coronavirus outbreak (1 work) · Clinical endpoint (1 work) · Cohort (1 work) · Confidence interval (1 work) · Coronavirus disease 2019 (COVID-19) (1 work) · Coronavirus Infections (1 work) · Cost effectiveness (1 work) · Cumulative incidence (1 work)